These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 28552199

  • 1. Cytoprotective effects of melatonin on zoledronic acid-treated human osteoblasts.
    Camacho-Alonso F, Urrutia-Rodríguez I, Oñate-Cabrerizo D, Oñate-Sánchez RE, Rodríguez-Lozano FJ.
    J Craniomaxillofac Surg; 2017 Aug; 45(8):1251-1257. PubMed ID: 28552199
    [Abstract] [Full Text] [Related]

  • 2. Cytoprotective effects of melatonin on zoledronic acid-treated human mesenchymal stem cells in vitro.
    Rodríguez-Lozano FJ, García-Bernal D, Ros-Roca Mde L, Algueró Mdel C, Oñate-Sánchez RE, Camacho-Alonso F, Moraleda JM.
    J Craniomaxillofac Surg; 2015 Jul; 43(6):855-62. PubMed ID: 26026888
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts.
    Zara S, De Colli M, di Giacomo V, Zizzari VL, Di Nisio C, Di Tore U, Salini V, Gallorini M, Tetè S, Cataldi A.
    Clin Oral Investig; 2015 Apr; 19(3):601-11. PubMed ID: 25055744
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells.
    Anitua E, Zalduendo M, Troya M, Orive G.
    Clin Oral Investig; 2016 Apr; 20(3):513-21. PubMed ID: 26201455
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Zoledronic acid inhibits human osteoblast activities.
    Basso FG, Silveira Turrioni AP, Hebling J, de Souza Costa CA.
    Gerontology; 2013 Apr; 59(6):534-41. PubMed ID: 23867757
    [Abstract] [Full Text] [Related]

  • 9. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties.
    Pozzi S, Vallet S, Mukherjee S, Cirstea D, Vaghela N, Santo L, Rosen E, Ikeda H, Okawa Y, Kiziltepe T, Schoonmaker J, Xie W, Hideshima T, Weller E, Bouxsein ML, Munshi NC, Anderson KC, Raje N.
    Clin Cancer Res; 2009 Sep 15; 15(18):5829-39. PubMed ID: 19737962
    [Abstract] [Full Text] [Related]

  • 10. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro.
    Huang X, Huang S, Guo F, Xu F, Cheng P, Ye Y, Dong Y, Xiang W, Chen A.
    Mol Med Rep; 2016 Jan 15; 13(1):613-22. PubMed ID: 26648136
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro synergistic effects of zoledronic acid and calcium on viability of human epithelial cells.
    Arai N, Inoue S, Tomihara K, Tsuno H, Noguchi M.
    Oral Dis; 2013 Mar 15; 19(2):200-5. PubMed ID: 22891943
    [Abstract] [Full Text] [Related]

  • 13. Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model.
    Saracino S, Canuto RA, Maggiora M, Oraldi M, Scoletta M, Ciuffreda L, Vandone AM, Carossa S, Mozzati M, Muzio G.
    J Oral Pathol Med; 2012 Nov 15; 41(10):788-92. PubMed ID: 22650360
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Study on the effects of zoledronic-acid-loaded collagen membrane on bone metabolism cells].
    Meng YH, Peng Y, Liu D, Chen Y, Wang H, Liang X.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Feb 15; 46(2):107-11. PubMed ID: 21426781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.